Weakly supervised deep learning approach to breast MRI assessment
MZ Liu, C Swintelski, S Sun, M Siddique, E Desperito… - Academic …, 2022 - Elsevier
Rationale and Objectives To evaluate a weakly supervised deep learning approach to
breast Magnetic Resonance Imaging (MRI) assessment without pixel level segmentation in …
breast Magnetic Resonance Imaging (MRI) assessment without pixel level segmentation in …
MRI appearance of invasive subcentimetre breast carcinoma: benign characteristics are common
M Meissnitzer, DD Dershaw, K Feigin… - The British Journal of …, 2017 - academic.oup.com
Objective: This study was undertaken to examine the characteristics of cancers detected at
the earliest possible point on MRI and to determine their significance. Methods: This …
the earliest possible point on MRI and to determine their significance. Methods: This …
Motion artifacts, lesion type, and parenchymal enhancement in breast MRI: what does really influence diagnostic accuracy?
Background Motion artifacts can reduce image quality of breast magnetic resonance
imaging (MRI). There is a lack of data regarding their effect on diagnostic estimates. Purpose …
imaging (MRI). There is a lack of data regarding their effect on diagnostic estimates. Purpose …
Foci on breast magnetic resonance imaging in high-risk women: cancer or not?
P Clauser, E Cassano, A De Nicolò, A Rotili… - La radiologia …, 2016 - Springer
Purpose To assess how frequently foci are identified on MRI in high-risk patients, and their
association with malignancy, breast density, and background parenchymal enhancement …
association with malignancy, breast density, and background parenchymal enhancement …
Outcomes of preoperative MRI-guided needle localization of nonpalpable mammographically occult breast lesions
Y Gao, NR Bagadiya, ML Jardon… - American Journal of …, 2016 - Am Roentgen Ray Soc
OBJECTIVE. MRI-guided needle localization allows access to MRI-detected
mammographically occult breast lesions that are not amenable to MRI-guided biopsy. The …
mammographically occult breast lesions that are not amenable to MRI-guided biopsy. The …
[HTML][HTML] Lesion characteristics, histopathologic results, and follow-up of breast lesions after MRI-guided biopsy
PURPOSE We aimed to assess the effectiveness of magnetic resonance imaging (MRI)-
guided vacuum-assisted breast biopsy (VABB), evaluate and compare the characteristics …
guided vacuum-assisted breast biopsy (VABB), evaluate and compare the characteristics …
Lésions classées ACR3 en IRM mammaire
M Armani, É Lissavarid, B Dyien, J Manceau… - Imagerie de la …, 2022 - Elsevier
Résumé Les lésions mammaires de catégorie 3 selon l'American College of Radiology
(ACR3) en IRM (incidence recommandée inférieure à 10%) ont une valeur prédictive …
(ACR3) en IRM (incidence recommandée inférieure à 10%) ont une valeur prédictive …
Are mammographically occult additional tumors identified more than 2 cm away from the primary breast cancer on MRI clinically significant?
S Goodman, V Mango, L Friedlander, E Desperito… - Academic …, 2019 - Elsevier
Rationale and Objectives To evaluate the clinical significance of mammographically occult
additional tumors identified more than 2cm away from the primary breast cancer on …
additional tumors identified more than 2cm away from the primary breast cancer on …
[PDF][PDF] Enhancing Foci on Breast MRI
A Choe, R Sivarajah - JAOCR, 2021 - cdn.agilitycms.com
Discussion In the American College of Radiology Breast Imaging Reporting and Data
System (ACR BI-RADS) Atlas, the breast MRI lexicon defines a focus as a unique enhancing …
System (ACR BI-RADS) Atlas, the breast MRI lexicon defines a focus as a unique enhancing …
[图书][B] Decision Support in Breast Cancer Treatment Using Deep Learning Features of Dynamic Contrast Enhanced Magnetic Resonance Imaging
MZ Liu - 2021 - search.proquest.com
Decision Support in Breast Cancer Treatment using Deep Learning Features of Dynamic
Contrast Enhanced Magnetic Resonance Imaging Page 1 Decision Support in Breast Cancer …
Contrast Enhanced Magnetic Resonance Imaging Page 1 Decision Support in Breast Cancer …